Yale 2019-nCoV SalivaDirect™ ValuPanel™ Reagents are now part of our ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19. For Research Use Only. Not for use in diagnostic procedures.
- Fast delivery: Product in stock ships same or next business day
- Gold standard quencher: From the trusted inventor and original source of Black Hole Quencher™ (BHQ™) technology referenced in 7 of 8 WHO protocols
- Quality manufacture: All probes and primers are HPLC purified and are manufactured and shipped from a facility entirely separate from positive control production.
|2019-nCoV_N1 Probe||FAM-ACC CCG CAT TAC GTT TGG TGG ACC-BHQ1|
|2019-nCoV_N1 Forward Primer||GAC CCC AAA ATC AGC GAA AT|
|2019-nCoV_N1 Reverse Primer||TCT GGT TAC TGC CAG TTG AAT CTG|
|Human RNase P Probe SalivaDirect||Quasar 670-TTC TGA CCT GAA GGC TCT GCG CG-BHQ2|
|Human RNase P Extraction Control Forward Primer||AGA TTT GGA CCT GCG AGC G|
|Human RNase P Extraction Control Reverse Primer||GAG CGG CTG TCT CCA CAA GT|